ABTI
Price:
$0.003
Market Cap:
$4.38M
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-05-05
Stock Exchange
PNK
Ticker
ABTI
According to Alterola Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.30. This represents a change of -110.47% compared to the average of 2.87 of the last 4 quarters.
The mean historical PE Ratio of Alterola Biotech, Inc. over the last ten years is -4082.31. The current -0.30 PE Ratio has changed -99.27% with respect to the historical average. Over the past ten years (40 quarters), ABTI's PE Ratio was at its highest in in the December 2015 quarter at 73.39K. The PE Ratio was at its lowest in in the September 2016 quarter at -15262.83.
Average
-4082.31
Median
-2311.60
Minimum
-15278.38
Maximum
-22.84
Discovering the peaks and valleys of Alterola Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.58%
Maximum Annual PE Ratio = -22.84
Minimum Annual Increase = -94.64%
Minimum Annual PE Ratio = -15278.38
Year | PE Ratio | Change |
---|---|---|
2023 | -22.84 | -12.73% |
2022 | -26.18 | -94.64% |
2020 | -488.74 | -11.09% |
2019 | -549.70 | -49.39% |
2018 | -1086.08 | -72.88% |
2017 | -4004.78 | -73.79% |
2016 | -15278.38 | 60.02% |
2015 | -9547.98 | 52.01% |
2014 | -6281.34 | 77.58% |
2013 | -3537.11 | -79.97% |
The current PE Ratio of Alterola Biotech, Inc. (ABTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-179.26
5-year avg
-434.71
10-year avg
-4082.31
Alterola Biotech, Inc.’s PE Ratio is less than Amexdrug Corporation (0), less than Aion Therapeutic Inc. (4.30), greater than Aspen Pharmacare Holdings Limited (-0.71), less than Antisense Therapeutics Limited (9.53), greater than The BC Bud Corporation (-3.23), greater than Crescita Therapeutics Inc. (-5.76), greater than null (-4.15),
Company | PE Ratio | Market cap |
---|---|---|
0 | $338.82K | |
4.30 | $1.98M | |
-0.71 | $5.44B | |
9.53 | $19.64M | |
-3.23 | $4.81M | |
-5.76 | $8.58M | |
-4.15 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterola Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alterola Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alterola Biotech, Inc.'s PE Ratio?
How is the PE Ratio calculated for Alterola Biotech, Inc. (ABTI)?
What is the highest PE Ratio for Alterola Biotech, Inc. (ABTI)?
What is the 3-year average PE Ratio for Alterola Biotech, Inc. (ABTI)?
What is the 5-year average PE Ratio for Alterola Biotech, Inc. (ABTI)?
How does the current PE Ratio for Alterola Biotech, Inc. (ABTI) compare to its historical average?